This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/russia/514421-merkel-welcomes-sputnik-vaccine-data/
The article has changed 4 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| ‘All vaccines welcome’: Merkel eyes Russia’s Sputnik V jab after ‘good data’ shows over 91% effectiveness in clinical trial | ‘All vaccines welcome’: Merkel eyes Russia’s Sputnik V jab after ‘good data’ shows over 91% effectiveness in clinical trial |
| (7 months later) | |
| Chancellor Angela Merkel has said she is open to Germany using Russia’s Sputnik V Covid-19 jab after a study in The Lancet reported its effectiveness as 91.6 percent against the virus overall and 100 percent against severe cases. | Chancellor Angela Merkel has said she is open to Germany using Russia’s Sputnik V Covid-19 jab after a study in The Lancet reported its effectiveness as 91.6 percent against the virus overall and 100 percent against severe cases. |
| “We have received good data today from the Russian vaccine,” Merkel said on Tuesday in a TV interview with public broadcaster ARD after interim analysis of Phase III clinical trial data was published by the esteemed British journal. | “We have received good data today from the Russian vaccine,” Merkel said on Tuesday in a TV interview with public broadcaster ARD after interim analysis of Phase III clinical trial data was published by the esteemed British journal. |
| “Every vaccine is welcome in the EU, but only after it has been approved by EMA,” Merkel said, referring to the European Medical Agency that regulates drugs. Merkel also said she had already spoken to Russian President Vladimir Putin about the prospect of the Sputnik V jab being administered in the EU. | “Every vaccine is welcome in the EU, but only after it has been approved by EMA,” Merkel said, referring to the European Medical Agency that regulates drugs. Merkel also said she had already spoken to Russian President Vladimir Putin about the prospect of the Sputnik V jab being administered in the EU. |
| Sputnik V was tested on 19,866 volunteers in the study, which found that it had an even higher efficacy of 91.8 percent among the 2,144 study subjects aged over 60 – and is also 100 percent effective against severe coronavirus cases. | Sputnik V was tested on 19,866 volunteers in the study, which found that it had an even higher efficacy of 91.8 percent among the 2,144 study subjects aged over 60 – and is also 100 percent effective against severe coronavirus cases. |
| The jab has already been approved for use outside Russia by 15 countries worldwide. | The jab has already been approved for use outside Russia by 15 countries worldwide. |
| The EMA has so far approved the three Covid-19 vaccines developed by Pfizer-BioNTech, Moderna, and the AstraZeneca-University of Oxford partnership, respectively, for use in the bloc. | The EMA has so far approved the three Covid-19 vaccines developed by Pfizer-BioNTech, Moderna, and the AstraZeneca-University of Oxford partnership, respectively, for use in the bloc. |
| The vaccine rollout across the EU’s 27 member states has been criticized as sluggish compared to nations like Israel, the US and UK, which have immunized higher percentages of their populations. | The vaccine rollout across the EU’s 27 member states has been criticized as sluggish compared to nations like Israel, the US and UK, which have immunized higher percentages of their populations. |
| Merkel has also come under fire in Germany over the country’s vaccination strategy, which has seen around three out of every 100 people given the jab, compared to the rate of 15 per 100 reported in the US and UK. | Merkel has also come under fire in Germany over the country’s vaccination strategy, which has seen around three out of every 100 people given the jab, compared to the rate of 15 per 100 reported in the US and UK. |
| On Monday, the chancellor responded to claims that the German vaccination strategy is inadequate, saying “something can always occur during production that cannot be anticipated.” | On Monday, the chancellor responded to claims that the German vaccination strategy is inadequate, saying “something can always occur during production that cannot be anticipated.” |
| Vaccination campaigns across the EU have been dogged by shortages of the Pfizer and AstraZeneca jabs. Both companies cited production issues at European manufacturing plants for a temporary drop in their projected deliveries. | Vaccination campaigns across the EU have been dogged by shortages of the Pfizer and AstraZeneca jabs. Both companies cited production issues at European manufacturing plants for a temporary drop in their projected deliveries. |
| Pfizer has since said it will deliver up to 75 million more vaccine doses in the second quarter of 2021, while AstraZeneca has pledged to deliver 40 million doses in the first quarter – 9 million more than it had previously promised after the production issues arose. | Pfizer has since said it will deliver up to 75 million more vaccine doses in the second quarter of 2021, while AstraZeneca has pledged to deliver 40 million doses in the first quarter – 9 million more than it had previously promised after the production issues arose. |
| Last week, the official Twitter account promoting the Sputnik V vaccine said that, if the jab is approved by EU regulators, the Russian Direct Investment Fund could provide the bloc with 100 million doses in the second quarter of this year. | Last week, the official Twitter account promoting the Sputnik V vaccine said that, if the jab is approved by EU regulators, the Russian Direct Investment Fund could provide the bloc with 100 million doses in the second quarter of this year. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |